Philip Aylward Selected Research

Philip Aylward Research Topics

Disease

14	Myocardial Infarction 01/2022 - 05/2007
12	Acute Coronary Syndrome 11/2020 - 06/2002
12	Stroke (Strokes) 12/2018 - 07/2008
12	Hemorrhage 10/2018 - 09/2010
5	ST Elevation Myocardial Infarction 01/2022 - 11/2012
5	Atrial Fibrillation 01/2020 - 06/2013
3	Infarction (Infarctions) 10/2014 - 05/2007
3	Embolism (Embolus) 09/2014 - 06/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2011
2	Ischemia 01/2022 - 06/2016
2	Inflammation (Inflammations) 01/2022 - 11/2012
2	Non-ST Elevated Myocardial Infarction 01/2022 - 10/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2014 - 05/2011
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Heart Failure 01/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Hemorrhagic Stroke 12/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018
1	Peripheral Arterial Disease 06/2016
1	Necrosis 10/2014
1	Unstable Angina 05/2011
1	Chronic Renal Insufficiency 09/2010

Drug/Important Bio-Agent (IBA)

9	TicagrelorIBA 01/2020 - 09/2010
6	Clopidogrel (Plavix)FDA Link 10/2018 - 09/2010
4	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 08/2013
4	apixabanIBA 09/2014 - 06/2013
4	Warfarin (Coumadin)FDA LinkGeneric 09/2014 - 06/2013
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 11/2012
2	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 01/2022 - 11/2012
2	C-Reactive ProteinIBA 01/2022 - 11/2012
2	CytokinesIBA 01/2022 - 11/2012
2	oxidized low density lipoproteinIBA 11/2020 - 11/2016
2	vorapaxarIBA 12/2018 - 01/2018
2	TroponinIBA 11/2012 - 05/2007
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	dapagliflozinIBA 01/2022
1	MitogensIBA 01/2022
1	LDL CholesterolIBA 11/2020
1	alirocumabIBA 11/2020
1	Lipoprotein(a)IBA 11/2020
1	Proprotein Convertase 9IBA 11/2020
1	Caffeine (No Doz)FDA LinkGeneric 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Thrombin Receptors (Thrombin Receptor)IBA 12/2018
1	Peptide Hydrolases (Proteases)FDA Link 12/2018
1	protease-activated receptor 4IBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2014
1	SumikagelIBA 10/2014
1	KAI 9803IBA 10/2014
1	delta proteinIBA 10/2014
1	MB Form Creatine KinaseIBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 10/2014
1	NexusIBA 11/2012
1	E 5555IBA 05/2011
1	Thrombin FDA Link 05/2011
1	CreatinineIBA 09/2010
1	AntithrombinsIBA 07/2008
1	bivalirudin (Angiomax)FDA Link 06/2002

Therapy/Procedure

5	Therapeutics 10/2019 - 03/2008
3	Percutaneous Coronary Intervention 10/2018 - 06/2002
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2014 - 08/2013
2	Secondary Prevention 01/2020 - 12/2018
1	Surgical Amputation (Amputations) 01/2022
1	Stents 10/2019
1	Thrombolytic Therapy 10/2018
1	Intravenous Infusions 10/2014
1	Patient Readmission 07/2008